Evidence-based dry-eye therapies for clinical use

CPD
1
8 October 2021
Volume 22, Issue 3

This article outlines a range of dry-eye disease management strategies available at each severity level and between subtypes of the disease.

Domains covered

Professionalism Clinical practice Specialty CPD (IP)

Despite recent advances in the management and treatment of dry-eye disease, the condition is still managed differently across continents and countries. From diagnosis to disease progression and treatment, patients should be well informed about the safe and effective use of available therapies. Consequently, this article aims to appraise eye care practitioners of a wide range of management strategies available at each severity level and between subtypes of dry-eye disease.

Sign in to continue

Forgotten password?
Register

Sign in to view the article

Not a member? Start enjoying the benefits of College membership today. Take a look at what the College can offer you and view our membership categories and rates.

Join the College today

Related further reading

Sleep apnoea and AMD: the emerging evidence

Adrian O’Dowd examines the evidence for a link between sleep apnoea and AMD, which could help optometrists assess the risk of vision loss quicker and more accurately.

AMD Public health

The hidden 'opia'

Hyperopia can be associated with reduced vision and educational outcomes but is easily overlooked. Helen Bird discovers the importance of detecting and correcting it in children, and how to address the challenge of communicating the need to parents.

Children

Northern Ireland member peer review (general and IP) - 9 October 2025

This is an in-person peer review taking place at Assembly Buildings, Belfast.

Cataract Children Glaucoma Referrals